CANCER THERAPEUTICS INNOVATION GROUP

Serial Number 85254485
606

Registration Progress

Application Filed
Mar 1, 2011
Under Examination
Mar 20, 2012
Approved for Publication
Jan 24, 2012
Published for Opposition
Jan 24, 2012
Registered

Trademark Image

CANCER THERAPEUTICS INNOVATION GROUP

Basic Information

Serial Number
85254485
Filing Date
March 1, 2011
Published for Opposition
January 24, 2012
Abandonment Date
October 27, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 27, 2014
Classes
042

Rights Holder

Cancer Therapeutics Innovation Group, LLC

16
Address
777 Third Avenue, Suite 14A
New York, NY 10017

Ownership History

Cancer Therapeutics Innovation Group, LLC

Original Applicant
16
Cambridge, MA

Cancer Therapeutics Innovation Group, LLC

Owner at Publication
16
New York, NY

Legal Representation

Attorney
Julia Huston, Esq.

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description Documents
Oct 27, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 27, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
May 21, 2014 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 21, 2014 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 15, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 14, 2014 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 31, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 1, 2014 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 30, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 29, 2013 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 27, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 27, 2013 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 16, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 15, 2013 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 13, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 13, 2013 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 11, 2013 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 18, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 17, 2012 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 17, 2012 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 14, 2012 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 14, 2012 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 20, 2012 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 24, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 24, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 4, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 21, 2011 ALIE A ASSIGNED TO LIE Loading...
Dec 21, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Dec 1, 2011 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 1, 2011 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 1, 2011 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 1, 2011 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 1, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 2, 2011 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 2, 2011 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 2, 2011 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 1, 2011 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 4, 2011 NWAP I NEW APPLICATION ENTERED Loading...
Mar 4, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 042
Conducting research and clinical trials relating to pharmaceuticals
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CANCER THERAPEUTICS" AND "GROUP"